Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry

Urology

Volumn 48, Issue 5, 1996, Pages 665-667

  McGrath, J C ^a   Lepor, H ^a   Wyllie, M G ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5!CHLORO 3 [2 [2 [2 (CYCLOPROPYLMETHOXY)PHENOXY]ETHYLAMINO] 2,2 DIMETHYLETHYL]INDOLE; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; DOXAZOSIN; PRAZOSIN; RECEPTOR SUBTYPE; TAMSULOSIN; TERAZOSIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; DRUG SELECTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEPTOR AFFINITY; SIDE EFFECT; VASCULAR RESISTANCE;

ADRENERGIC ALPHA-ANTAGONISTS; DRUG INDUSTRY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0029964881     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00425-6     Document Type: Article

References (0)